Evidence for a role tumor necrosis factor α in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease

Metabolism: Clinical and Experimental

Volumn 47, Issue 1, 1998, Pages 113-118

  Jovinge, Stefan ^b   Hamsten, Anders ^b   Tornvall, Per ^b   Proudler, Anthony ^b   Be̊venholm, Peter ^b   Ericsson, Carl Göran ^b   Godsland, Ian ^b   De Faire, Ulf ^b   Nilsson, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE PREDISPOSITION; GLUCOSE METABOLISM; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031908483     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90203-7     Document Type: Article

References (35)

1. Old LJ: Tumor necrosis factor (TNF)- Science 230:630-633, 1985
2. Beutler B, Cerami A: The biology of cachectin/TNF - A primary mediator of the host response. Annu Rev Immunol 7:625-655, 1989
3. Barath P, Fishbein M, Cao J, et al: Detection and localization of tumour necrosis factor in human atheroma. Am J Pathol 65:297-302, 1990
4. Tipping PG, Hancock WW: Production of tumor necrosis factor and interleukin-1 by macrophages from atheromatous plaque. Am J Pathol 142:1721-1728, 1993
5. Rouzer CA, Cerami A: Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removal. Mol Biochem Parasitol 2:31-38, 1980
6. Feingold KR, Serio MK, Adi S, et al: Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology 124:2336-2342, 1989
7. Kawakami M, Cerami A: Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 154:631-639, 1981
8. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α A key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
9. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
10. Hotamisligil GS, Budavari A, Murray D, et al: Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J Clin Invest 94:1543-1549,1994
11. Hotamisligil GS, Murray DL, Choy LN, et al: Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA91:4854-4858, 1994
12. Hotamisligil GS, Arner P, Caro JF, et al: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
13. Kern PA, Saghizadeh M, Ong JM, et al: The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
14. Saghizadeh M, Ong JM, Garvey WT, et al: The expression of TNFα by human muscle. Relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
15. Båvenhohn P, Malmberg K, Efendic S, et al: Hypcrinsulinaemia, hypertriglyceridaemia and impaired fibrinolytic function: Concordant abnormalities associated with myocardial infarction at young age. Nutr Metab Cardiovasc Dis 3:28-37, 1993
16. Malmberg K, Båvenholm P, Hamsten A: Clinical and biochemical factors associated with prognosis after myocardial infarction at young age. J Am Coll Cardiol 24:592-599, 1994
17. Tornvall P, Båveholm P, Landou C, et al: Relationship of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 88:2180-2189, 1993
18. de Faire U, Ericsson C-G, Hamsten A, et al: Design features of a five-year Bezafibrate Coronary Atherosclerosis Intervention Trial (BE-CAIT). Drugs Exp Clin Res 21:105-124, 1995
19. Ericsson CG, Hamsten A, Nilsson J, et al: Angiographic assessment of the effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 347:849-853, 1996
20. Reaven TG, Bernstein R, Davis B, et al: Non-ketotic diabetes mellitus: Insulin deficiency or insulin resistance? Am J Med 60:80-88, 1976
21. Carlson K: Lipoprotein fractionation. J Clin Pathol 5:32-37, 1973
22. Proundler AJ, Godsland IF, Stevenson JC: Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements. Metabolism 43:446-449, 1995
23. Matthews DR, Hosher JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
24. Chmielewska J, Rånby M, Wiman B: Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 31:427-436, 1983
25. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45-52, 1966
26. Reiber MC, Serruys PW: Quantitative coronary angiography, in Reiber JHC (ed): Developments in Cardiovascular Medicine. Dordrecht, The Netherlands, Kluwer Academic, 1991
27. Austen WG, Edwards JE, Frye RL, et al: A reporting system on patients evaluated for coronary artery disease. Circulation 51:5-40, 1975
28. Hamsten A, Walldius G, Szamosi A, et al: Relationship of angiographically denned coronary artery disease to serum lipoproteins in young survivors of myocardial infarction. Circulation 73:1097-1110, 1986
29. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
30. Hamsten A, Blombäck M, Wiman B, et al: Haemostatic function in myocardial infarction. Br Heart J 55:58-66, 1986
31. Sadur C, Eckel R: Insulin stimulation of adipose tissue lipoprotein lipase. J Clin Invest 69:1119-1125, 1982
32. Coppack SW, Evans RD, Fisher RM, et al: Adipose tissue metabolism in obesity: Lipase action before and after a mixed meal. Metabolism 41:264-272, 1992
33. Reaven G, Mondon C: Effect of in vivo plasma insulin levels on the relationship between perfusate free fatty acid concentration and triglyceride secretion by perfused rat livers. Horm Metab Res 16:230-232, 1984
34. Randle P, Garland P, Hales C, et al: The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
35. Groop LC, Saloranta C, Shank M, et al: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insuhn-dependent diabetes mellitus. J Clin Endocrinol Metab 72:96-107, 1991